Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
BMC Geriatrics|February 6, 2026
"We can do this. That I learned.": A nonrandomized open pilot of Resilient Together for Dementia, a post-diagnosis dyadic interventionGrace O Allison, Sydney McCage, Stephan Brandt, et al.Bjpsych Open|September 6, 2022
Effects of psilocybin versus escitalopram on rumination and thought suppression in depressionTommaso Barba, Sarah Buehler, Hannes Kettner, et al.Neuroscience Insights|October 10, 2024
Neuroimaging and the Investigation of Drug-Drug Interactions Involving PsychedelicsMatthew B Wall, Rebecca Harding, Natalie Ertl, et al.Scientific Reports|February 7, 2024
Psychedelics and sexual functioning: a mixed-methods studyTommaso Barba, Hannes Kettner, Caterina Radu, et al.Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.General Hospital Psychiatry|January 5, 2024
Association between cardiac event-induced PTSD symptoms and daily intrusive thoughts about cardiac risk: An ecological momentary assessment studyJeffrey L Birk, Talea Cornelius, Ian M Kronish, et al.Journal of Patient Safety|August 10, 2022
Critical Care Clinicians' Experiences of Patient Safety During the COVID-19 PandemicAmanda Rosen, Danielle Carter, Jo R Applebaum, et al.Journal of Affective Disorders|October 25, 2021
The association between sleep and psychological distress among New York City healthcare workers during the COVID-19 pandemicFranchesca Diaz, Talea Cornelius, Sean Bramley, et al.Frontiers in Psychology|September 18, 2015
A perfect storm: examining the synergistic effects of negative and positive emotional instability on promoting weight loss activities in anorexia nervosaEdward A Selby, Talea Cornelius, Kara B Fehling, et al.Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.Pageof 11